Comparative Analysis of the Informative Value of Radioimmunoassay and Laser Correlation Spectroscopy in Myasthenia Gravis

Abstract

The objective of this study was to compare informative value of traditional approach (anti-AChR antibody radioimmunoassay) and evaluation of metabolic shifts by laser correlation spectroscopy in myasthenia gravis. The method based on changes in spectral characteristics of laser radiation caused by scattering in a disperse system yields a histogram reflecting particle contribution into light scatter as a function of particle radius in nanometers. The spectrum of anti-AChR-positive serum is characterized by appreciably increased contribution of particles with a radius 4.6–6.2 nm. Binding of serum components with solubilized AChR confirms that this peak is determined by elevated concentration of antibodies to this receptor. The search for the relationship between the disease severity and the distribution pattern of subfraction serum components revealed three informative zones: 6–15, 27–67, and 127–223 nm. In patients without disturbances of vital functions, the contribution of the first zone particles into light scatter increases and that of the third zone particles decreases. Considerable differences attaining the level of statistical significance in zones 4–6 and 20 nm were revealed in the spectra of serum from patients with myasthenia gravis of the same severity with and without thymoma. This opens prospects for dynamic monitoring of the efficiency of therapy.

The Complex of Tests for the Quantitative Evaluation of the Effects of Radiation on Laboratory Animals

“…LCS allows measuring particle size in native biological fluids. It is successfully used in clinical practice for evaluation of the disease severity and treatment efficiency in patients with asthma, diabetes mellitus, myasthenia, some haematological diseases, and other pathologies [5,6,[7][8][9][10].…”

Interaction of Titanium Dioxide Nanoparticles and Blood Serum of Patients with Bronchial Asthma and Myasthenia Gravis

“…The detected binding of nanoparticles with large immune complexes typical of severe forms of myasthenia gravis [13] is of undoubted practical importance. At present, plasmapheresis is used for removal of circulating immune complexes from the blood in myasthenia patients.…”